OsteoVantage Inc:製品パイプライン分析

◆英語タイトル:OsteoVantage Inc - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010101
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月27日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥219,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥328,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OsteoVantage Inc (OsteoVantage) is a medical device company that develops osteogenic spinal instrumentation technology used in spinal fusion procedures. The company’s INDOS system is an osteogenic spinal instrumentation for use in lumbar spinal fusion procedures. It also offers osteomodulation technology for non-pharmacological remodeling of bone. OsteoVantage’s products finds applications in minimizing pain and improving clinical results through improved bone fusion technologies for the treatment of degenerative diseases, back injuries, fractures, and other orthopedic and dental disorders, among others. The company offers product for spine injury treatments. It conducts research to optimize the instrumentation performance. OsteoVantage is headquartered in Fayetteville, Arkansas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OsteoVantage Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
OsteoVantage Inc Company Overview 4
OsteoVantage Inc Company Snapshot 4
OsteoVantage Inc Pipeline Products and Ongoing Clinical Trials Overview 4
OsteoVantage Inc – Pipeline Analysis Overview 7
OsteoVantage Inc – Key Facts 7
OsteoVantage Inc – Major Products and Services 8
OsteoVantage Inc Pipeline Products by Development Stage 9
OsteoVantage Inc Pipeline Products Overview 11
Electroconductive Mesh 11
Electroconductive Mesh Product Overview 11
INDOS System 12
INDOS System Product Overview 12
Osteogenic Device – Long Bone Repair 13
Osteogenic Device – Long Bone Repair Product Overview 13
OsteoVantage Inc – Key Competitors 14
OsteoVantage Inc – Key Employees 15
OsteoVantage Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 19
Contact Us 19
Disclaimer 20

List of Tables
OsteoVantage Inc Pipeline Products and Ongoing Clinical Trials Overview 4
OsteoVantage Inc Pipeline Products by Equipment Type 5
OsteoVantage Inc Pipeline Products by Indication 6
OsteoVantage Inc, Key Facts 7
OsteoVantage Inc, Major Products and Services 8
OsteoVantage Inc Number of Pipeline Products by Development Stage 9
OsteoVantage Inc Pipeline Products Summary by Development Stage 10
Electroconductive Mesh - Product Status 11
Electroconductive Mesh - Product Description 11
INDOS System - Product Status 12
INDOS System - Product Description 12
Osteogenic Device - Long Bone Repair - Product Status 13
Osteogenic Device - Long Bone Repair - Product Description 13
OsteoVantage Inc, Key Employees 15
Glossary 18

★海外企業調査レポート[OsteoVantage Inc:製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tenaga Nasional Bhd (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Bhd (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Alliqua BioMedical Inc (ALQA):医療機器:M&Aディール及び事業提携情報
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protecti …
  • Daepyung Co., Ltd.:企業の戦略・SWOT・財務情報
    Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vonage Holdings Corp:企業の戦略・SWOT・財務分析
    Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Natural Resource Partners L.P.:企業のM&A・事業提携・投資動向
    Natural Resource Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Natural Resource Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Intel Corporation:企業のM&A・事業提携・投資動向
    Intel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …
  • Swiss Life Holding Ltd:企業のM&A・事業提携・投資動向
    Swiss Life Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Life Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Cyclopharm Ltd (CYC):企業の財務・戦略的SWOT分析
    Cyclopharm Ltd (CYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • bluebird bio Inc (BLUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immuno …
  • MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報
    Summary Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that offers research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management o …
  • Bisnode AB:企業のM&A・事業提携・投資動向
    Bisnode AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bisnode AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • The Alfred Mann Foundation:製品パイプライン分析
    Summary The Alfred Mann Foundation (AMF) is a medical instutute that develops medical devices and commercializes solutions for significant medical conditions. The institute conducts research in the therapeutic areas of neuromuscular disorders, diabetes, limb loss, and chronic pain. It provides neuro …
  • Havells India Ltd (HAVELLS):企業の財務・戦略的SWOT分析
    Havells India Ltd (HAVELLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bonnier AB:企業の戦略的SWOT分析
    Bonnier AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Owens-Illinois, Inc.:企業の戦略・SWOT・財務分析
    Owens-Illinois, Inc. - Strategy, SWOT and Corporate Finance Report Summary Owens-Illinois, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lee & Man Paper Manufacturing Ltd:戦略・SWOT・企業財務分析
    Lee & Man Paper Manufacturing Ltd - Strategy, SWOT and Corporate Finance Report Summary Lee & Man Paper Manufacturing Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • NeuroSearch AS (NEUR)-製薬・医療分野:企業M&A・提携分析
    Summary NeuroSearch A/S (NeuroSearch) focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system (CNS) through license agreements with other life science companies. The company divested all rights of Huntexil for the treatment of patien …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆